Click here to see the original post on AdPharm

Visit AdPharm.net for more pharmaceutical ads

Click on thumbnail to view the full-size ad on AdPharm

In depression and in GAD

Discover the power of Cipralex

Now covered in Ontario and BC

Brand name: Cipralex
Generic name/category: Escitalopram, Enantiopure drugs, Nitriles, Selective serotonin reuptake inhibitors (SSRI)
Company: Lundbeck
Country/Market: Canada, North America
Indication(s)/use: Depression and Generalized Anxiety Disorder (GAD)
Target: Healthcare Professionals (HCP)
Tagline: Discover the power of Cipralex
Medium: Print ad
Size/duration: single-page
Publication/Aired: CMAJ – September 15, 2009

To see all of this brand’s ads on AdPharm, click here

Click on thumbnail to view the full-size ad on AdPharm

Treat his hemophelia A and… Get him in the action.

Helixate FS is an advanced recombinant factor VIII therapy.

Brand name: Helixate FS
Generic name/category: Antihemophilic Factor (Recombinant)
Company: CSL Behring
Country/Market: USA, North America
Indication(s)/use: Hemophilia
Target: Healthcare Professionals (HCP)
Tagline: Take life on
Medium: Print ad
Size/duration: single-page
Publication/Aired: Blood – August 27, 2009

To see all of this brand’s ads on AdPharm, click here

nowosc -
rewolucja w walce z nadwaga
New -
A revolution in the fight against weight

Orlistat (marketed as a prescription under the trade name Xenical by Roche or over-the-counter as Alli by GlaxoSmithKline), also known as tetrahydrolipstatin, is a drug designed to treat obesity. Its primary function is preventing the absorption of fats from the human diet, thereby reducing caloric intake. It is intended for use in conjunction with a physician-supervised reduced-calorie diet. Orlistat is the saturated derivative of lipstatin, a potent natural inhibitor of pancreatic lipases isolated from the bacterium Streptomyces toxytricini. However, due to simplicity and stability, orlistat rather than lipstatin was developed into an anti-obesity drug.

The effectiveness of orlistat in promoting weight loss is definite, though modest. Pooled data from clinical trials suggests that people given orlistat in addition to lifestyle modifications, such as diet and exercise, lose about 2–3 kilograms (4.4–6.6 lb) more than those not taking the drug. Orlistat also modestly reduces blood pressure, and appears to prevent the onset of type 2 diabetes, whether due to weight loss itself or to other effects; in a large randomized controlled trial, orlistat was found to reduce the incidence of diabetes by nearly 40% in obese people.

More on Wikipedia

Brand name: Alli
Generic name/category: Orlistat, Antiobesity drugs, Lactones
Company: GlaxoSmithKline Consumer Healthcare (GSK)
Country/Market: Poland, Europe
Indication(s)/use: obesity
Target: Healthcare Professionals (HCP)
Medium: Print ad
Size/duration: single-page
Publication/Aired: Gazeta Farmaceutyczna – September 2009

To see all of this brand’s ads on AdPharm, click here

Alli, nueva solución para ayudarte a perder un 50% más de peso.
Alli, a new solution to help you lose 50% more weight.

Orlistat (marketed as a prescription under the trade name Xenical by Roche or over-the-counter as Alli by GlaxoSmithKline), also known as tetrahydrolipstatin, is a drug designed to treat obesity. Its primary function is preventing the absorption of fats from the human diet, thereby reducing caloric intake. It is intended for use in conjunction with a physician-supervised reduced-calorie diet. Orlistat is the saturated derivative of lipstatin, a potent natural inhibitor of pancreatic lipases isolated from the bacterium Streptomyces toxytricini. However, due to simplicity and stability, orlistat rather than lipstatin was developed into an anti-obesity drug.

The effectiveness of orlistat in promoting weight loss is definite, though modest. Pooled data from clinical trials suggests that people given orlistat in addition to lifestyle modifications, such as diet and exercise, lose about 2–3 kilograms (4.4–6.6 lb) more than those not taking the drug. Orlistat also modestly reduces blood pressure, and appears to prevent the onset of type 2 diabetes, whether due to weight loss itself or to other effects; in a large randomized controlled trial, orlistat was found to reduce the incidence of diabetes by nearly 40% in obese people.

More on Wikipedia

Brand name: Alli
Generic name/category: Orlistat, Antiobesity drugs, Lactones
Company: GlaxoSmithKline Consumer Healthcare (GSK)
Country/Market: Spain, Europe
Indication(s)/use: obesity
Target: Consumers (DTC)
Medium: Print ad
Size/duration: single-page
Publication/Aired: Psychologies – August 2009

To see all of this brand’s ads on AdPharm, click here

To prevent and potentially reverse many of the symptoms of Type 1 Gaucher Disease
Cerezyme leads the way

Proven efficacy and safety for over 14 years

Brand name: Cerezyme
Generic name/category: Imiglucerase for injection
Company: Genzyme
Country/Market: USA, North America
Indication(s)/use: Gaucher’s Disease
Target: Healthcare Professionals (HCP)
Tagline: Leads the way
Medium: Print ad
Size/duration: single-page
Publication/Aired: Blood – September 17, 2009

Administrez-vous le vaccin Gardasil aux jeunes femmes?
Recommand?© par le CCNI pour les filles et les femmes ag?©es de 9 a 26 ans.

Do you administer the Gardasil vaccine to young women?
Recommended by CCNI for girls and women ages 9 to 26 years.

Gardasil (Merck & Co.), also known as Gardisil or Silgard, is a vaccine against certain types of human papillomavirus (HPV).

Gardasil is designed to prevent infection with HPV types 16, 18, 6, and 11. HPV types 16 and 18 that currently cause about 70% of cervical cancer cases, and also cause some vulvar, vaginal, penile and anal cancers. HPV types 6 and 11 cause about 90% of genital warts cases.

Gardasil is only effective in preventing HPV infections, not in treating those already infected by HPV, and so the vaccine must be given before HPV infection occurs in order to be effective. For this reason it is recommended to administer the vaccine before adolescence and the onset of sexual activity.

More on Wikipedia

Brand name: Gardasil
Generic name/category: Vaccines, Papillomavirus
Company: Merck Frosst
Country/Market: Canada, North America
Indication(s)/use: human papillomavirus (HPV) types 6, 11, 16 and 18 infection prevention
Target: Healthcare Professionals (HCP)
Medium: Print ad
Size/duration: single-page
Publication/Aired: Le M?©decin Du Qu?©bec – Septembre 2009

To see all of this brand's ads on AdPharm, click here
0 views
Sep 09, 2009

Visit AdPharm.net for more pharmaceutical ads